Trending...
- The Law Offices of Steinhardt, Siskind and Lieberman, LLC Celebrates 35 Years - 103
- MoArk Dental & Implants Introduces Yomi Robotic Technology for Implant Surgery
- Building A Business Website That Works In 2025
Communities deserve answers on the potential role psychotropic drugs and treatments may have in senseless acts of violence—an issue too long suppressed by vested interests.
LOS ANGELES - Michimich -- By CCHR International
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Michimich.com
Regulators have long issued warnings:
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Michimich.com
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Families and communities deserve answers about the potential role psychiatric drugs may play in senseless acts of violence—an issue suppressed for decades by vested interests. The Citizens Commission on Human Rights International (CCHR) is urging that the National Institutes of Health (NIH) study on psychotropic drugs and violence be given the full weight it deserves, warning that dismissing it would betray the public's right to safety and truth.
The NIH has been directed to investigate studies to shed light on the link between psychiatric drugs, particularly SSRI (Selective Serotonin Reuptake Inhibitor) antidepressants, and violence. CCHR President Jan Eastgate stressed: "The significance of this lies in its potential to open a conversation long silenced—how mind-altering drugs, prescribed to millions, may contribute to acts of senseless violence, from shootings to stabbings and assaults that devastate families."
Cocaine, methamphetamine, and alcohol are widely recognized as risk factors for aggression. "Why should prescription psychotropics be treated differently? Families deserve truth, not excuses," Eastgate added.
Tennessee in 2025 mandated toxicology testing for psychotropic drugs in autopsies after certain mass shootings—a landmark policy CCHR says should be expanded nationwide to cover all mass acts of violence.[1] A Florida Senator has announced plans to file a bill requiring disclosure of whether perpetrators of mass or terroristic violence had taken antidepressants, citing public safety concerns.
In 2000, the New York State Senate proposed tracking violent crimes committed by individuals tested for psychotropic drugs. The bill stalled in committee, but had it passed, a reporting system would already be in place.
Concerns are not new. In 1989, at a Kentucky coroner's inquest, a psychiatrist testified that an antidepressant influenced a workplace shooting in which eight people were killed. Since then, medical experts across the U.S. and internationally have raised alarm over violent acts linked to psychiatric drugs, while the industry has resisted scrutiny.
More on Michimich.com
- DGiTK – Digital Technologies, LLC Announces Groundbreaking Partnership with Hyperscale Compute Partner to Revolutionize Data Sovereignty in the U.S
- Delirious Comedy Club Expands to Two Rooms and Secures Google's #1 Rated Comedy Club in Las Vegas
- SPOZZ, the Community-Owned Direct-to-Fan Music Ecosystem, adds "BEATS" — a Creator-to-Creator Marketplace
- Frankenmuth Dog Bowl and Frankenmuth River Place Shops Earn 19 International Awards
- DAECO Painting Sets the Gold Standard for High-End Interior Painting Services in Denver, CO
Regulators have long issued warnings:
- The Food and Drug Administration (FDA) has logged at least 1,530 reports of homicide or homicidal ideation associated with psychiatric drugs.
- FDA advisories (2004, 2005) highlighted risks of agitation, hostility, and suicidal behavior on antidepressants. It also warns of homicidal ideation with one SSRI.[2]
- Health Canada warned of SSRIs' "potential for harm, including suicidal thoughts and the onset or worsening of agitation-type adverse events."[3]
- Australian regulators linked stimulants such as dextroamphetamine and atomoxetine to homicidal thoughts.[4]
- The European Medicines Agency reported increased aggression in children and adolescents taking SSRIs.[5]
- FDA Black Box Warnings already acknowledge suicidal thoughts on drugs such as the ADHD drug Strattera (atomoxetine hydrochloride) and antidepressants.
The Violence Project's Mass Shooter Database reports at least 24% of shooters had been on psychotropics—a figure likely underestimated due to limited access to medical records.[6] Independent researchers, including Professors Peter C. Gøtzsche and David Healy, have published data showing increased aggression linked to SSRIs.[7]
The FDA admitted in 2007 that all patients on antidepressants should be closely monitored for agitation, hostility, aggression, or unusual behavior.[8] Professor Healy has explained that drug-induced agitation is a major causal factor in suicide and violence, with about 5% of patients dropping out of trials for this reason—ten times the placebo rate.[9] Applied to 45 million Americans on antidepressants, that risk could potentially affect 2.25 million people.
Withdrawal adds further risks. The UK Royal College of Psychiatrists warns that stopping antidepressants can trigger anger, agitation, suicidal impulses, or akathisia—an intense inner restlessness linked to violence. These effects may persist for weeks, months, or longer.[10] "Too often, such reactions are misrepresented by vested interests as a perpetrator merely stopping treatment, rather than serious drug-induced withdrawal effects," Eastgate said.
Recent tragedies highlight the issue:
- U.S. and European incidents in 2025 revealed perpetrators with histories of psychiatric drug treatment or active prescriptions.
- Investigators in Sweden concluded that one mass killer acted under the influence of amphetamine and sedative drugs.
- Reports from Tennessee, Florida, New York, and Germany similarly documented psychiatric drugs in connection with acts of mass violence.
While not every individual reacts violently, evidence shows that a subset does—and families deserve to be informed of the risks.
More on Michimich.com
- Boston Industrial Solutions Expands Availability of Industry-Leading Primers to Mexico
- Unprescribed™ Introduces the Focus, Mood & Mind System™
- Texas Mechanic Unveils "Mighty Mule" Experimental Pontiac Engine—Delivering Over Triple the Factory Horsepower
- $20 Target in Noble Capital Markets Report Supported by Live Stream of 1ST Global Super League Kerala Event from AI Powered Sports Leader: $SEGG
- Michigan Collection Attorneys Share the Secret to Dealing with Difficult Debtor Personalities
Violence is not a symptom of mental illness. As Dr. Jonathan Metzl of Vanderbilt University notes, no psychiatric diagnosis includes homicidal behavior. Substance-induced states, however, are well-recognized causes of violence.
Other influences also matter. Programs such as "death education" and court-mandated anger management have shaped violent behavior in some cases. Two U.S. school shooters in Columbine, Colorado—one taking an SSRI—had been instructed in class to imagine and write about their own deaths. One described a shooting spree—then weeks later, enacted it.[11]
Eastgate emphasized: "Investigating this issue does not mean excusing crime. It means transparency, accountability, and willingness to examine all possible causes, rather than protecting commercial interests. To ignore prescription psychotropics despite regulatory warnings and clinical evidence is reckless."
CCHR argues that honest inquiry is essential:
- Families who lost loved ones deserve clear answers.
- Communities living in fear need prevention strategies grounded in science, not industry spin.
- Policymakers must have accurate data to legislate effectively.
CCHR has published a documented report, Psychiatric Drugs: Create Violence & Suicide—School Shootings and Other Acts of Senseless Violence.
CCHR is a non-profit mental health industry watchdog founded in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz. For more than five decades, it has investigated and exposed psychiatric abuse, leading to reforms and protections worldwide.
Sources:
[1] www.thegatewaypundit.com/2025/04/ablechild-tennessee-sets-national-precedent-passage-ablechild-bill/
[2] "Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – Nov. 2005
[3] www.canada.ca/en/news/archive/2004/06/health-canada-advises-canadians-stronger-warnings-ssris-other-newer-anti-depressants.html
[4] Australian Therapeutic Goods Administration "Product Information safety updates"
[5] Ibid.
[6] www.theviolenceproject.org/mass-shooter-database/
[7] www.madinamerica.com/2024/08/violence-caused-by-antidepressants-ignored-once-again-by-psychiatrists/; www.eventbrite.com/e/antidepressants-and-homicide-automatism-spectrum-disorders-tickets-1020994190107
[8] www.cchrint.org/2024/10/11/cchr-wants-increased-consumer-awareness-about-prescriptions-for-violence/; www.bmj.com/content/358/bmj.j3697
[9] www.bmj.com/content/358/bmj.j3697
[10] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/; www.researchgate.net/publication/335329642_Antidepressant_withdrawal_-_the_tide_is_finally_turning
[11] www.washingtontimes.com/news/2002/aug/18/20020818-040825-5515r/
Source: Citizens Commission on Human Rights International
Filed Under: Health
0 Comments
Latest on Michimich.com
- HuskyTail Digital Marketing Rings in Fall with Free SEO Audits for Local Businesses
- David White DDS Advances Implant Dentistry with New Technology Acquisition
- Final Countdown: The OpenSSL Conference 2025 Begins in One Week
- New Frontier Aerospace Appoints Industry Veteran Rich Pournelle as Director of Business Development
- AI's Urgent Energy Requirements Won't Be Solved By Trillions Of Dollars. Phinge's Patented App-Less Netverse Platform & Hardware Will Reduce This Need
- $750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
- €6.4 Million in Contracts Across Multiple Countries; Smart City Developer; U.S. Expansion, and Announces Strategic Drone Tech Partnership; $AFFU
- CRYPTOCURRENCY: Lucrumia Exchange Platform Addresses Italian Traders' Growing Demand for Secure Digital Asset Trading
- NIUFO Launches Secure Trading Platform for Italian Market Seeking Stability After 20% User Decline
- OrderDomains.com Empowers Businesses with Premium Domains and Flexible Financing
- Cryptocurrency Trading: AHRFD Enters German Market with Institutional-Grade Infrastructure
- TSWHZC Launches Automated Copy Trading Platform for Brazil's 28 Million Crypto Users
- Keyanb Crypto Exchange Unveils Comprehensive Platform Architecture for Chilean Traders Seeking Lower Fees and Enhanced Security
- Phoenix Advocacy Network Launches to Amplify Survivor Voices and Advance Disability Rights
- Matecrypt Platform Delivers Comprehensive Solution for Argentine Traders with 200+ Cryptocurrencies and 2 Million Orders Per Second Processing
- Wzzph Exchange Expands Brazilian Market Access with Comprehensive Trading Platform
- CCHR: Prescription Psychotropics Fuel America's Addiction and Overdose Crisis
- The Truth Behind Egypt's Stolen Legacy: Livestream
- Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing
- 'ChilCorp – Water' Builds Momentum After Being Named as a Qualified Team in $119M XPRIZE Water Scarcity Global Competition